Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.435
+0.045 (1.88%)
May 21, 2026, 1:20 PM EDT - Market open
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $421.35 million as of May 21, 2026. Its market cap has increased by 1,965.42% in one year.
Market Cap
421.35M
Enterprise Value
261.03M
1-Year Change
1,965.42%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has increased from $301.40M to $421.35M, an increase of 39.80%. That is a compound annual growth rate of 3.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 446.10M | 284.24% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 431.15M |
| PureTech Health | 426.13M |
| Replimune Group | 426.07M |
| Neurogene | 425.86M |
| Fulcrum Therapeutics | 423.12M |
| Assembly Biosciences | 417.34M |
| ADC Therapeutics | 412.10M |
| Sagimet Biosciences | 410.65M |